Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Share This

Latest Mizuho News

See all news
Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

March 20, 2026
Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

March 13, 2026
Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

March 17, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue